- Home
- OPAL vs MNOV Comparison
OPAL vs MNOV Comparison
Compare OPAL & MNOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OPAL | MNOV |
|---|---|---|
| Founded | 1998 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Natural Gas Distribution | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 78.3M | 72.7M |
| IPO Year | N/A | 2005 |
Fundamental Metrics
Financial Performance| Metric | OPAL | MNOV |
|---|---|---|
| Price | $2.26 | $1.39 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 4 | 2 |
| Target Price | $2.81 | ★ $7.00 |
| AVG Volume (30 Days) | ★ 375.0K | 80.1K |
| Earning Date | 11-06-2025 | 02-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.02 | N/A |
| Revenue | ★ $329,243,000.00 | $257,917.00 |
| Revenue This Year | $17.15 | N/A |
| Revenue Next Year | $22.04 | N/A |
| P/E Ratio | $100.79 | ★ N/A |
| Revenue Growth | ★ 7.26 | N/A |
| 52 Week Low | $1.26 | $1.13 |
| 52 Week High | $4.08 | $2.20 |
Technical Indicators
Market Signals| Indicator | OPAL | MNOV |
|---|---|---|
| Relative Strength Index (RSI) | 44.18 | 50.77 |
| Support Level | $2.57 | $1.25 |
| Resistance Level | $2.87 | $1.34 |
| Average True Range (ATR) | 0.22 | 0.05 |
| MACD | -0.02 | -0.00 |
| Stochastic Oscillator | 27.59 | 58.62 |
Price Performance
Historical ComparisonAbout OPAL OPAL Fuels Inc.
OPAL Fuels Inc is a fully integrated, nationwide leader in the production and distribution of low-carbon intensity renewable natural gas. The company is also engaged in the marketing and distribution of RNG to heavy-duty trucking and other hard-to-de-carbonize industrial sectors. The company designs, develops, constructs, operates, and services Fueling Stations for trucking fleets across the country that use natural gas to displace diesel as their transportation fuel. The company derives revenue from the sale of Renewable Power, design, development, construction, and service of Fueling Stations, and sales of RNG produced by OPAL and third parties as pipeline-quality natural gas.
About MNOV Medicinova Inc
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's strategies are to focus its developing activities on therapeutics for neurological disorders and fibrotic diseases.